SQZ Biotechnologies Company
SQZ was delisted on the 3rd of July, 2023.
49 hedge funds and large institutions have $159M invested in SQZ Biotechnologies Company in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 7 reducing their positions, and 9 closing their positions.
271% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 7
28% more capital invested
Capital invested by funds: $125M → $159M (+$34.7M)
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
4% more funds holding
Funds holding: 47 → 49 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12.9M |
| 2 |
6CM
683 Capital Management
New York
|
+$10.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.81M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.85M |
| 5 |
JP Morgan Chase
New York
|
+$2.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
-$9.96M |
| 2 |
AI
Alphabet Inc
Mountain View,
California
|
-$9.5M |
| 3 |
CCM
CAAS Capital Management
New York
|
-$1.8M |
| 4 |
LM
Luminus Management
Houston,
Texas
|
-$1.52M |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$711K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Walleye Capital
New York
| – | -$903 | -66,008 | Closed |
|
|
52
Tudor Investment Corp
Stamford,
Connecticut
| – | -$711K | -51,998 | Closed |
|
53
Millennium Management
New York
| – | -$425K | -31,033 | Closed |
|
54
Squarepoint
New York
| – | -$233K | -17,038 | Closed |
|
55
D.E. Shaw & Co
New York
| – | -$227K | -16,593 | Closed |
|
56
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
| – | -$18K | -1,300 | Closed |
|
57
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$2K | -183 | Closed |
|
|
HI
58
Harbour Investments
Madison,
Wisconsin
| – | -$13 | -1 | -5% |
|
SQZ Hedge Fund Activity: Q2 2021 in Review
49 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q2 2021, worth a combined $159M — up 28% from $125M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new SQZ positions and 9 closed out — a net gain of 2 holders — while 26 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $12.9M. The largest seller was Bridger Management, exiting entirely with an estimated $9.96M sold.
- 49 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q2 2021, up from 47 in Q1 2021.
- Funds reported $159M of SQZ Biotechnologies Company stock for Q2 2021, up 28% quarter-over-quarter.
- 11 funds opened new SQZ Biotechnologies Company positions in Q2 2021 and 9 closed out, a net change of +2 holders.
- The largest SQZ Biotechnologies Company buyer in Q2 2021 was BlackRock, an estimated $12.9M added.
- The largest SQZ Biotechnologies Company seller in Q2 2021 was Bridger Management, an estimated $9.96M sold.
Based on aggregated 13F filings for Q2 2021.